Subscribe to Newsletter

COVID-19

Discovery & Development Clinical Trials

Regeneron on the Digital Age of Clinical Trials

| 6 min read

The world is taking more interest in clinical trials. How are clinical trials adapting? Regeneron’s Bari Kowal keeps us updated.

Business & Regulation Profession

Interviews To Inspire

| Jamie Irvine

Our roundup of some of our thoughtful and inspiring video interviews and roundtables from the past year.

Manufacture Vaccines

The Shadow of COVID-19

| Stephanie Vine | 10 min read

How the European Commission has struck deals to secure manufacturing capacity for future emergencies.

Discovery & Development Drug Discovery

Reaching for RNA

| Stephanie Vine | 7 min read

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Discovery & Development Drug Discovery

Nobel Prize for mRNA COVID-19 Vaccine Technology

| Stephanie Vine | 7 min read

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Business & Regulation Business Practice

Pfizer Fallout

| Stephanie Vine | 3 min read

The pharma giant’s COVID-19 vaccine saved millions of lives, but the company is quickly falling from grace.

Discovery & Development Advanced Medicine

Video Interview: Phil Vanek on the Importance of Regulatory Harmonization

| Stephanie Vine

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

Discovery & Development Advanced Medicine

Video: Angela Osborne Discusses the Latest Cell and Gene Industry Trends

| Stephanie Vine

Check out our latest video interview with Angela Osborne who discusses the latest cell and gene industry trends.

Discovery & Development Formulation

Llamas – and Yeast Display – to the Rescue

| Jamie Irvine | 2 min read

Modified screening process optimizes nanobodies for sustainable COVID-19 treatments derived from llamas.

Discovery & Development Formulation

Barking up the Right Tree

| Jamie Irvine | 2 min read

Researchers use genome mining and bioengineering techniques to develop sustainable saponin-based vaccine adjuvants


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register